Abstract:RNA modifications are mostly dynamically reversible post-transcriptional modifications, of which m6A is the most prevalent in eukaryotic mRNAs. A growing number of studies indicate that RNA modification can finely tune gene expression and modulate RNA metabolic homeostasis, which in turn affects the self-renewal, proliferation, apoptosis, migration, and invasion of tumor cells. Endometrial carcinoma (EC) is the most common gynecologic tumor in developed countries. Although it can be diagnosed early in the onset and have a preferable prognosis, some cases might develop and become metastatic or recurrent, with a worse prognosis. Fortunately, immunotherapy and targeted therapy are promising methods of treating endometrial cancer patients. Gene modifications may also contribute to these treatments, as is especially the case with recent developments of new targeted therapeutic genes and diagnostic biomarkers for EC, even though current findings on the relationship between RNA modification and EC are still very limited, especially m6A. For example, what is the elaborate mechanism by which RNA modification affects EC progression? Taking m6A modification as an example, what is the conversion mode of methylation and demethylation for RNAs, and how to achieve selective recognition of specific RNA? Understanding how they cope with various stimuli as part of in vivo and in vitro biological development, disease or tumor occurrence and development, and other processes is valuable and RNA modifications provide a distinctive insight into genetic information. The roles of these processes in coping with various stimuli, biological development, disease, or tumor development in vivo and in vitro are self-evident and may become a new direction for cancer in the future. In this review, we summarize the category, characteristics, and therapeutic precis of RNA modification, m6A in particular, with the purpose of seeking the systematic regulation axis related to RNA modification to provide a better solution for the treatment of EC.

RNA m6A methylation regulators in endometrial cancer (Review)

Shining a Spotlight on M6a and the Vital Role of RNA Modification in Endometrial Cancer: a Review

Interaction Between N6-methyladenosine Modification and the Tumor Microenvironment in Colorectal Cancer

The emerging roles of N6-methyladenosine RNA methylation in human cancers

Single-cell N6-methyladenosine Regulator Patterns Guide Intercellular Communication of Tumor Microenvironment That Contribute to Colorectal Cancer Progression and Immunotherapy

The Implications of N6-methyladenosine (m6a) Modification in Esophageal Carcinoma

The Emerging Molecular Mechanism of M6a Modulators in Tumorigenesis and Cancer Progression

Emerging Roles of m6A RNA Methylation Regulators in Gynecological Cancer

A comprehensive review of m6A research in cervical cancer

Emerging Roles of RNA Methylation in Gastrointestinal Cancers

m6A modification of RNA in cervical cancer: role and clinical perspectives

The Roles of M6a RNA Modifiers in Human Cancer

The roles of m<SUP>6</SUP>A RNA modifiers in human cancer

N<SUP>6</SUP>-methyladenosine as a biological and clinical determinant in colorectal cancer: progression and future direction

Functions and mechanisms of RNA m6A regulators in breast cancer (Review)

Effects of N6-Methyladenosine Modification on Cancer Progression: Molecular Mechanisms and Cancer Therapy

Recent advances of m6A methylation modification in esophageal squamous cell carcinoma

RNA methylation and breast cancer: insights into m6A, m7G and m5C

The Diverse Role of RNA Methylation in Esophageal Cancer

The role of m6A RNA methylation in human cancer

m6A Regulators Is Differently Expressed and Correlated With Immune Response of Esophageal Cancer